One of the most exciting frontiers in biogerontology is senolysis, the targeted elimination of senescent "zombie" cells. These damaged cells refuse to die, secreting a toxic inflammatory cocktail known as the SASP (Senescence-Associated Secretory Phenotype) that degrades surrounding healthy tissue. FOXO4-DRI is designed specifically to dismantle this destructive cycle.
Disrupting the FOXO4 and p53 Interaction
Senescent cells survive by using the FOXO4 protein to sequester p53, a critical tumor suppressor and apoptosis regulator. FOXO4-DRI (D-Retro-Inverso peptide) acts as a high-affinity competitor, selectively binding to FOXO4 and releasing p53 to trigger programmed cell death exclusively in senescent cells.
- Targeted Senolysis: Induces apoptosis in senescent fibroblasts while leaving healthy, youthful cells entirely unharmed.
- SASP Suppression: Shuts down the chronic release of pro-inflammatory cytokines like IL-6 and matrix metalloproteinases.
- Tissue Rejuvenation: Restores normal tissue architecture and improves functional capacity in aged animal models.
Synthesizing complex D-amino acid peptides like FOXO4-DRI requires immense precision. Poorly synthesized batches from overseas often fail our rigorous €300+ third-party HPLC/MS testing due to incorrect chirality or missing protective groups. By ordering from our European depot, you avoid customs seizures and receive certified, lab-verified research material every time.
Ready to elevate your research? Explore our lab-verified Longevity Peptides and Complete Research Kits today with batch-specific COAs and fast European shipping.